These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25025052)

  • 21. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
    Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
    Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.
    Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH
    Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency.
    Tafaleng EN; Chakraborty S; Han B; Hale P; Wu W; Soto-Gutierrez A; Feghali-Bostwick CA; Wilson AA; Kotton DN; Nagaya M; Strom SC; Roy-Chowdhury J; Stolz DB; Perlmutter DH; Fox IJ
    Hepatology; 2015 Jul; 62(1):147-57. PubMed ID: 25690322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatic involvement in hereditary alpha-1-antitrypsin deficiency].
    Lachaux A; Dumortier J
    Rev Mal Respir; 2014 Apr; 31(4):357-64. PubMed ID: 24750955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sirtuin3 promotes the degradation of hepatic Z alpha-1 antitrypsin through lipophagy.
    Poole B; Oshins R; Huo Z; Aranyos A; West J; Duarte S; Clark VC; Beduschi T; Zarrinpar A; Brantly M; Khodayari N
    Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular inclusions containing mutant alpha1-antitrypsin Z are propagated in the absence of autophagic activity.
    Kamimoto T; Shoji S; Hidvegi T; Mizushima N; Umebayashi K; Perlmutter DH; Yoshimori T
    J Biol Chem; 2006 Feb; 281(7):4467-76. PubMed ID: 16365039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in alpha-1-antitrypsin deficiency liver disease.
    Teckman JH; Jain A
    Curr Gastroenterol Rep; 2014 Jan; 16(1):367. PubMed ID: 24338605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for alpha-1 antitrypsin deficiency: an update.
    Pires Ferreira D; Gruntman AM; Flotte TR
    Expert Opin Biol Ther; 2023 Mar; 23(3):283-291. PubMed ID: 36825473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
    Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
    Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-1-Antitrypsin Deficiency Liver Disease.
    Patel D; Teckman JH
    Clin Liver Dis; 2018 Nov; 22(4):643-655. PubMed ID: 30266154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver disease associated with alpha1-antitrypsin deficiency.
    Rosen HR
    Clin Liver Dis; 1998 Feb; 2(1):175-85. PubMed ID: 15560052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
    Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
    Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A C. elegans model of human α1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnover.
    Long OS; Benson JA; Kwak JH; Luke CJ; Gosai SJ; O'Reilly LP; Wang Y; Li J; Vetica AC; Miedel MT; Stolz DB; Watkins SC; Züchner S; Perlmutter DH; Silverman GA; Pak SC
    Hum Mol Genet; 2014 Oct; 23(19):5109-22. PubMed ID: 24838286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.
    Khan Z; Yokota S; Ono Y; Bell AW; Oertel M; Stolz DB; Michalopoulos GK
    Gene Expr; 2017 Feb; 17(2):115-127. PubMed ID: 27938510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FBG1 Is the Final Arbitrator of A1AT-Z Degradation.
    Wen JH; Wen H; Gibson-Corley KN; Glenn KA
    PLoS One; 2015; 10(8):e0135591. PubMed ID: 26295339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency.
    Gruntman AM; Flotte TR
    Methods Mol Biol; 2017; 1639():267-275. PubMed ID: 28752467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage disease.
    Puls F; Goldschmidt I; Bantel H; Agne C; Bröcker V; Dämmrich M; Lehmann U; Berrang J; Pfister ED; Kreipe HH; Baumann U
    J Hepatol; 2013 Sep; 59(3):626-30. PubMed ID: 23707368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
    Tang Y; Fickert P; Trauner M; Marcus N; Blomenkamp K; Teckman J
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G156-65. PubMed ID: 27102560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Perlmutter DH
    Pediatr Res; 2006 Aug; 60(2):233-8. PubMed ID: 16864711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.